Browse by Journal Title

Article

Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in Graves' disease patient blood.
Degen, H., Gavvovidis, I., Blankenstein, T., Uhland, K. and Ungerer, M.
Thyroid 31 (6): 950-963. June 2021

A new highly thyrotropin receptor-selective small molecule antagonist with potential for the treatment of Graves' orbitopathy.
Marcinkowski, P., Hoyer, I., Specker, E., Furkert, J., Rutz, C., Neuenschwander, M., Sobottka, S., Sun, H., Nazare, M., Berchner-Pfannschmidt, U., von Kries, J.P., Eckstein, A., Schülein, R. and Krause, G.
Thyroid 29 (1): 111-123. 23 January 2019

RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells.
Medapati, M.R., Dahlmann, M., Ghavami, S., Pathak, K.A., Lucman, L., Klonisch, T., Hoang-Vu, C., Stein, U. and Hombach-Klonisch, S.
Thyroid 25 (5): 514-527. 4 May 2015

Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
Kim, T.D., Schwarz, M., Nogai, H., Grille, P., Westermann, J., Ploeckinger, U., Braun, D., Schweizer, U., Arnold, R., Doerken, B. and le Coutre, P.
Thyroid 20 (11): 1209-1214. 9 November 2010